Women's Hospital School Of Medicine Zhejiang University
Clinical trials sponsored by Women's Hospital School Of Medicine Zhejiang University, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Breath test could help prevent brain damage in jaundiced newborns Results expected Dec 2026 (estimated)
- Major study launches to unravel mysteries of early menopause Results expected Dec 2026 (estimated)
- Could a simple surgery replace chemo for this rare Pregnancy-Related cancer? Results expected Dec 2026 (estimated)
- Which surgery works best for scar pregnancy? new study aims to find out Results expected Dec 2026 (estimated)
- New combo therapy aims to stop cervical cancer return Results expected Dec 2026 (estimated)
-
Can a natural compound boost chemotherapy against endometrial cancer?
Disease control Not yet recruitingThis trial is testing whether adding elemene liposomes—a compound derived from a traditional Chinese medicinal plant—to standard chemotherapy (carboplatin and paclitaxel) can help people with advanced or recurrent endometrial cancer. Participants will receive either the combinati…
Phase 2 • Sponsor: Women's Hospital School Of Medicine Zhejiang University • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Could a drug combo replace the knife for some endometrial cancers?
Disease control Not yet recruitingThis study tests two immunotherapy drugs (iparomlimab and tuvonralimab) in 30 women with a specific type of endometrial cancer that is mismatch repair-deficient. The goal is to see if the treatment can make the cancer disappear or shrink enough to avoid surgery. Participants must…
Phase 2 • Sponsor: Women's Hospital School Of Medicine Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New Immunotherapy-Chemo cocktail aims to boost cervical cancer survival
Disease control Not yet recruitingThis phase 2 trial tests whether adding the immunotherapy drug ivonescimab to chemotherapy before standard chemoradiation can improve outcomes for women with high-risk, locally advanced cervical cancer. About 42 participants will receive two cycles of the combination, then procee…
Phase 2 • Sponsor: Women's Hospital School Of Medicine Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New blood test could spot cervical cancer early in High-Risk women
Diagnosis Not yet recruitingThis study aims to develop a blood test that can accurately detect serious cervical lesions in women infected with HPV16 or HPV18, the high-risk types linked to cervical cancer. Researchers will collect blood samples and medical data from about 1,465 women across three hospitals …
Sponsor: Women's Hospital School Of Medicine Zhejiang University • Aim: Diagnosis
Last updated Jun 27, 2026 12:38 UTC
-
AI coaching may turn novice ultrasound operators into expert-level diagnosticians
Knowledge-focused Not yet recruitingThis trial tests whether an AI system can guide junior sonographers, those with less than three years of experience, to scan and diagnose ovarian masses more accurately. Participants undergo ultrasound exams performed by these sonographers, either with or without AI assistance. R…
Sponsor: Women's Hospital School Of Medicine Zhejiang University • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC